Glucagon-like peptide 1 (GLP-1) is a bioactive peptide produced by ileal enteroendocrine L cells, originally approved for treating type II diabetes and obesity [11,12]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.